IP Verse

The Regents Of The University Of California opposition analysis

COMPANY ANALYSIS

Latest patents of The Regents Of The University Of California opposed by its competitors

Patent:
EP3250693
Grant Date:
Dec 20, 2023
Title:
Protein Delivery In Primary Hematopoietic Cells
Oppositions:
1
Patent:
EP3597749
Grant Date:
Jul 26, 2023
Title:
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
Oppositions:
3
Patent:
EP2906696
Grant Date:
Dec 14, 2022
Title:
Methods For Modulating C9Orf72 Expression
Oppositions:
2
Patent:
EP1793855
Grant Date:
Jan 19, 2022
Title:
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease
Oppositions:
1
Patent:
EP3615667
Grant Date:
Aug 11, 2021
Title:
Microorganisms And Methods For Producing Cannabinoids And Cannabinoid Derivatives
Oppositions:
2
Patent:
EP3604339
Grant Date:
Mar 10, 2021
Title:
Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same
Oppositions:
1
Patent:
EP2328553
Grant Date:
Jun 10, 2020
Title:
Corticosteroids For The Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract
Oppositions:
1
Patent:
EP2535044
Grant Date:
Dec 18, 2019
Title:
Enterically Coated Cysteamine, Cystamine And Derivatives Thereof
Oppositions:
1
Patent:
EP2709672
Grant Date:
Dec 18, 2019
Title:
Compositions And Methods For Treating Retinal Diseases
Oppositions:
1
Patent:
EP3401400
Grant Date:
Apr 3, 2019
Title:
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
Oppositions:
4

Competitors of The Regents Of The University Of California

HGF LIMITED

POHLMAN, SANDRA M.

GREAVES BREWSTER LLP

Want to track The Regents Of The University Of California?

Feel free to send us a message here and we will get back to you